Reflux Pharmaceuticals
Eiko Lifesciences Acquires 25.01% Stake In Reflux Pharmaceuticals
Banking - Published date: .
The acquisition is part of ELL's long-term strategic growth plan to diversify its portfolio and enter new markets Read more